Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae119 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJS Open, 2024. Verfasst von Adam D Gerrard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Referral and Consultation, Occult Blood, Early Detection of Cancer. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, Scotland, Cancer Research UK, Scottish Government.
Abstract (Originalsprache)
Background
This study aimed to describe the faecal immunochemical test non-return rate of those referred with high-risk symptoms of colorectal cancer from primary care, and the clinical outcomes of the ‘non-returners’.
Methods
From January 2019 to July 2021, patients referred to secondary care with symptoms suspicious of colorectal cancer and a referral priority of urgent or urgent suspicion of cancer were sent a faecal immunochemical test. All patients were investigated regardless of faecal immunochemical test return or result. Demographics and clinical outcomes such as colorectal cancer prevalence were compared between those who returned a faecal immunochemical test and non-returners.
Results
Of 7345 patients included in the study, 874 (11.9%) did not return a faecal immunochemical test. Non-returner characteristics included male sex (P = 0.040), younger age (median age 57 versus 65 years, P < 0.001), per rectal bleeding (P < 0.001) and lower socioeconomic status (median Scottish Index of Multiple Deprivation, 6 versus 7, P < 0.001) compared with those who returned a faecal immunochemical test. Of 6294 patients undergoing colorectal investigation, there was a greater prevalence of colorectal cancer (5.4% versus 3.6% P = 0.032) and significant bowel pathology than in the non-returners (15.3% versus 9.8%, P < 0.001). With a median follow-up of 25 months, the colorectal cancer prevalence for the entire 7345 cohort was equal between those who returned and did not return a faecal immunochemical test (3.2% versus 3.8%, P = 0.108). Of note, the non-returners diagnosed with colorectal cancer were younger (median age 64 versus 73 years, P < 0.001) and from a lower socioeconomic area (median Scottish Index of Multiple Deprivation 4 versus 7, P = 0.015) than faecal immunochemical test returners.
Conclusion
Patients referred to secondary care, with symptoms suspicious of colorectal cancer, that did not return a faecal immunochemical test had a similar colorectal cancer prevalence to those that returned the test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
- Department of Colorectal Surgery, Western General Hospital, Edinburgh, UK.
- Department of Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
- Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
- UK Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Cancer, Western General Hospital, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Adam D Gerrard, Yasuko Maeda, Evropi Theodoratou, Malcolm G Dunlop
Förderung
- Chief Scientist Office, Scotland
- Cancer Research UK
- Scottish Government
- CRUK Career Development Fellowship
Zitieren
APA
Gerrard, A. D., Coxon, J., Maeda, Y., Theodoratou, E., Dunlop, M. G., & Din, F. V. N. (2024). Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways. BJS Open. https://doi.org/10.1093/bjsopen/zrae119
Vancouver
Gerrard AD, Coxon J, Maeda Y, Theodoratou E, Dunlop MG, Din FVN. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways. BJS Open. 2024. doi:10.1093/bjsopen/zrae119
BibTeX
@article{Gerrard2024,
author = {Gerrard, Adam D and Coxon, Jonty and Maeda, Yasuko and Theodoratou, Evropi and Dunlop, Malcolm G and Din, Farhat V N},
title = {Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae119}
}
EUVIMED